Etoposide, cyclophosphamide, total body irradiation and allogeneic stem cell transplantation for hematologic malignancies at a single institution.

被引:0
|
作者
Bishop, MR [1 ]
Tarantolo, SR [1 ]
Bierman, PJ [1 ]
Vose, JM [1 ]
Reed, EC [1 ]
Gross, TG [1 ]
Pavletic, ZS [1 ]
Spinolo, J [1 ]
Kollath, J [1 ]
Nasrati, K [1 ]
Armitage, JO [1 ]
Kessinger, A [1 ]
机构
[1] UNIV NEBRASKA,MED CTR,OMAHA,NE
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2450 / 2450
页数:1
相关论文
共 50 条
  • [41] Clinical efficacy and feasibility of an intensive preparative regimen with busulfan, cyclophosphamide, and total body irradiation followed by allogeneic stem cell transplantation for patients with myeloid malignancies.
    Yano, Shingo
    Asai, Osamu
    Dobashi, Nobuaki
    Osawa, Hiroshi
    Takei, Yutaka
    Yahagi, Yuichi
    Takahara, Shinobu
    Ogasawara, Yoji
    Otsubo, Hiroko
    Yamaguchi, Yuko
    Minami, Jiro
    Maruyama, Dai
    Kobayashi, Tatsunosuke
    Hoshi, Yasutaka
    Usui, Noriko
    BLOOD, 2006, 108 (11) : 401B - 401B
  • [42] Thiotepa and fractionated TBI conditioning prior to allogeneic stem cell transplantation for advanced hematologic malignancies: a phase II single institution trial
    Devetten, MP
    Qazilbash, MH
    Beall, CL
    Bunner, P
    Weisenborn, R
    Lynch, JP
    Ericson, SG
    BONE MARROW TRANSPLANTATION, 2004, 34 (07) : 577 - 580
  • [43] Effects of total body irradiation-based conditioning on allogeneic stem cell transplantation for pediatric acute leukemia: a single-institution study
    Park, Jongmoo
    Choi, Eun Kyung
    Kim, Jong Hoon
    Lee, Sang-Wook
    Song, Si Yeol
    Yoon, Sang Min
    Kim, Young Seok
    Kim, Su Ssan
    Park, Jin-Hong
    Park, Jaehyeon
    Do Ahn, Seung
    RADIATION ONCOLOGY JOURNAL, 2014, 32 (03): : 198 - 207
  • [44] Thiotepa and fractionated TBI conditioning prior to allogeneic stem cell transplantation for advanced hematologic malignancies: a phase II single institution trial
    M P Devetten
    M H Qazilbash
    C L Beall
    P Bunner
    R Weisenborn
    J P Lynch
    S G Ericson
    Bone Marrow Transplantation, 2004, 34 : 577 - 580
  • [45] Total body irradiation, busulfan and cyclophosphamide as a conditioning regimen for allogeneic bone marrow transplantation for patients with hematological malignancies
    Kai, S
    Misawa, M
    Hara, H
    JAPANESE JOURNAL OF TRANSPLANTATION, 1999, 34 (04) : 191 - 199
  • [46] Phase I/II results of cyclophosphamide (CY) VP-16, carboplatin (CBDCA) and total body irradiation (TBI) with autologous stem cell transplantation for hematologic malignancies
    Gray, F
    Shea, T
    Wiley, J
    Serody, J
    Powell, E
    LaChapelle, J
    Pope, B
    Sailer, S
    Bentley, S
    Brecher, M
    BLOOD, 1995, 86 (10) : 3778 - 3778
  • [47] Effects of the Order of Administration of Total Body Irradiation and Cyclophosphamide on the Outcome of Allogeneic Hematopoietic Cell Transplantation
    Motohashi, Kenji
    Fujisawa, Shin
    Onizuka, Makoto
    Kako, Shinichi
    Sakaida, Emiko
    Shono, Katsumichi
    Tatara, Raine
    Doki, Noriko
    Mori, Takehiko
    Sakura, Toru
    Aotsuka, Nobuyuki
    Ogusa, Eriko
    Tomita, Naoto
    Kawai, Nobutaka
    Saitoh, Takayuki
    Usuki, Kensuke
    Taguchi, Jun
    Kanamori, Heiwa
    Takahashi, Satoshi
    Okamoto, Shinichiro
    BLOOD, 2014, 124 (21)
  • [48] Total body irradiation, cyclophosphamide, and etoposide with stem cell transplant as treatment for infants with acute lymphocytic leukemia
    Pirich, L
    Haut, P
    Morgan, E
    Marymount, M
    Kletzel, M
    MEDICAL AND PEDIATRIC ONCOLOGY, 1999, 32 (01): : 1 - 6
  • [49] Organ sparing total marrow irradiation compared to total body irradiation prior to allogeneic stem cell transplantation
    Haraldsson, Andre
    Wichert, Stina
    Engstrom, Per E.
    Lenhoff, Stig
    Turkiewicz, Dominik
    Warsi, Sarah
    Engelholm, Silke
    Back, Sven
    Engellau, Jacob
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2021, 107 (04) : 393 - 407
  • [50] THE ORDER OF ADMINISTRATION OF CYCLOPHOSPHAMIDE AND TOTAL BODY IRRADIATION DOES NOT AFFECT THE OUTCOME OF PATIENTS UNDERGOING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Solano, J.
    Gonzalez, A. J.
    Gutierrez, L.
    Duenas, V.
    Martinez-Mugica, C.
    Martinez, D.
    Palomo, P.
    Gonzalez, A. P.
    Gonzalez, S.
    Rayon, C.
    Vallejo, C.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S480 - S481